Veterinary Medicines

PRONESTESIC 40 mg/ml + 0.036 mg/ml solution for injection for horses, cattle, swine and sheep

Authorised
  • Procaine hydrochloride
  • ADRENALINE TARTRATE PH. EUR.
Download as PDF

Product identification

Medicine name:
PRONESTESIC 40 mg/ml + 0.036 mg/ml solution for injection for horses, cattle, swine and sheep
PRONESTESIC 40 mg/ml + 0,036 mg/ml SOLUCION INYECTABLE PARA CABALLOS BOVINO PORCINO Y OVINO
Active substance:
  • Procaine hydrochloride
  • ADRENALINE TARTRATE PH. EUR.
Target species:
  • Cattle
  • Sheep
  • Pig
  • Horse
Route of administration:
  • Perineural use
  • Subcutaneous use

Product details

Active substance and strength:
  • Procaine hydrochloride
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • ADRENALINE TARTRATE PH. EUR.
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Perineural use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BA52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3399 ESP
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0238/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
Spanish (PDF)
Published on: 17/03/2023
Download

Package Leaflet

English (PDF)
Published on: 25/12/2023
Download
Spanish (PDF)
Published on: 17/03/2023
Download

Labelling

English (PDF)
Published on: 25/12/2023
Download
Spanish (PDF)
Published on: 17/03/2023
Download

Combined File of all Documents

English (PDF)
Published on: 21/11/2022
Download

eu-PUAR-esv0238001-dcp-pronestesic-40-mg-ml-+-0.036-mg-ml-solution-for-injection-for-horses--cattle--swine-and-sheep-en.pdf

English (PDF)
Published on: 22/12/2023
Download

es-puar-pronestesic-40-mg-ml-+-0.036-mg-ml-solution-for-injection-for-horses--cattle--swine-and-sheep-es.pdf

Spanish (PDF)
Published on: 17/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."